STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

November 29, 2021
Review

Apoptosis, Pyroptosis, and Necroptosis-Oh My! The Many Ways a Cell Can Die.

Journal of Molecular Biology
Natalia Ketelut-Carneiro, Katherine A Fitzgerald
October 28, 2021
Open Access

UMP-CMP kinase 2 gene expression in macrophages is dependent on the IRF3-IFNAR signaling axis.

PloS One
Hera KimRichard K Kandasamy
September 16, 2021
Correction

Author Correction: ZCCHC3 is a co-sensor of cGAS for dsDNA recognition in innate immune response.

Nature Communications
Huan LianHong-Bing Shu
August 18, 2021
Comment / Editorial

Igniting the firestorm: The inflammasome in autoinflammatory syndromes.

The Journal of Allergy and Clinical Immunology
Fiachra Humphries, Katherine A Fitzgerald
June 25, 2021

Cellular nucleic acid-binding protein is essential for type I interferon-mediated immunity to RNA virus infection.

Proceedings of the National Academy of Sciences of the United States of America
Yongzhi ChenKatherine A Fitzgerald
March 20, 2021
Open Access

Lung Epithelial Cell Transcriptional Regulation as a Factor in COVID-19-associated Coagulopathies.

American Journal of Respiratory Cell and Molecular Biology
Ethan S FitzGeraldAmanda M Jamieson
January 5, 2021
Review

Overcoming innate immune barriers that impede AAV gene therapy vectors.

The Journal of Clinical Investigation
Manish MuhuriGuangping Gao
December 15, 2020
Open Access

The long non-coding RNA LUCAT1 is a negative feedback regulator of interferon responses in humans.

Nature Communications
Shiuli AgarwalKatherine A Fitzgerald
November 19, 2020
Open Access

Ensuring vaccine safety

Science
David M KnipeElke Mühlberger
November 5, 2020
Correction
Open Access

Author Correction: Caspase-8 mediates inflammation and disease in rodent malaria

Nature Communications
Larissa M N PereiraRicardo T Gazzinelli
September 16, 2020
Open Access

Caspase-8 mediates inflammation and disease in rodent malaria.

Nature Communications
Larissa M N PereiraRicardo T Gazzinelli
August 21, 2020

Succination inactivates gasdermin D and blocks pyroptosis.

Science
Fiachra HumphriesKatherine A Fitzgerald

Sign up to follow this feed and discover related papers.

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Basophils

Basophils are myeloid cells with a high affinity IgE receptor and is involved in inflammatory responses during allergy. Discover the latest research on Basophils here.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.

© 2022 Meta ULC. All rights reserved
/feed-previews/sting-receptor-agonists/ccea472e-fa73-4b76-9db5-85e1f1d25eea